Information  X 
Enter a valid email address

Eden Research plc (EDE)

  Print      Mail a friend       Annual reports

Thursday 30 June, 2011

Eden Research plc

DTR - Shares in Issue

                                                                                          30 June 2011

                                           EDEN RESEARCH PLC
                                       ("Eden" or the "Company")

                                         DTR - Shares in Issue

In  accordance with the FSA's Disclosure and Transparency Rules, Eden confirms that as of 30 June 2011
the Company has 99,303,596 Ordinary Shares of 1p  each in issue.

The voting rights of all of these shares are identical.

The Directors of Eden are responsible for the contents of this announcement.

For further information please contact:


Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl


Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk

Eden Research plc								


a d v e r t i s e m e n t